Glyphroxine sodium glucose cotransporter 2 inhibitor method for lowering blood glucose using pharmaceutical composition

摘要

By administering glyphroxine sodium glucose cotransporter inhibitor drug composition to a person certified to obtain a store of glyphrodin sodium glucose cotransporter inhibitor drug composition A method for reducing blood glucose in subjects requiring it is provided.In some embodiments, the glyphroxine sodium glucose cotransporter inhibitor pharmaceutical composition comprises englyglyphin, canine glyphrodin, and eltzglyolol.In some embodiments, the glyphrosin sodium glucose cotransporter inhibitor pharmaceutical composition comprises (2S, 3R, 4R, 5S, 6R) - 2 - [4-chloro-3 - (4-ethoxyphenyl) methyl] phenyl] - 6 - (hydroxymethyl) oxane-3,4, or Contains 5-triol or its pharmaceutically acceptable salt.